Bayer Announces Primary Endpoint Achieved in Phase III FINEARTS-HF Cardiovascular …08/05/2024 majac Heart Disease “Bayer is determined to drive research and innovations that have the potential to become treatment options for diseases with high unmet medical need, …Share on FacebookTweetFollow usSave